The Headwinds of Specialty Drug Management

As employers face multiple headwinds in managing specialty drug spend, traditional PBM models lack alignment and incentives to fully address these issues for their clients. Check out this insightful article published in JMCP on these challenges and the implications for plan sponsors working for a sustainable drug benefit.